scorecardresearchIOL Chemicals & Pharmaceuticals Share Price Live NSE, BSE, Today - IOL
Mintgenie
Asian Paints3,300.706.85 (0.21%)
Axis Bank1,026.0011.90 (1.17%)
Bajaj Finance7,838.65-32.15 (-0.41%)
Bajaj Finserve1,566.15-1.80 (-0.11%)
Bharti Airtel919.607.45 (0.82%)
HCL Technologies1,261.550.95 (0.08%)
HDFC Bank1,527.20-10.45 (-0.68%)
Hindustan Unilever2,501.3021.65 (0.87%)
ICICI Bank943.15-5.40 (-0.57%)
ITC449.106.70 (1.51%)
Indusind Bank1,439.0015.50 (1.09%)
Infosys1,467.557.50 (0.51%)
Kotak Mahindra Bank1,765.252.60 (0.15%)
Larsen & Toubro2,961.7049.40 (1.70%)
Mahindra & Mahindra1,590.15-5.25 (-0.33%)
Maruti Suzuki India10,699.65150.05 (1.42%)
NTPC239.35-0.85 (-0.35%)
Nestle India22,905.95-96.75 (-0.42%)
Power Grid Corporation Of India199.350.95 (0.48%)
Reliance Industries2,369.1027.55 (1.18%)
State Bank Of India589.50-4.80 (-0.81%)
Sun Pharmaceutical Industries1,141.0016.25 (1.44%)
Tata Consultancy Services3,587.654.50 (0.13%)
Tata Motors620.400.65 (0.10%)
Tata Steel128.15-0.70 (-0.54%)
Tech Mahindra1,288.656.30 (0.49%)
Titan Company3,221.75-40.55 (-1.24%)
Ultratech Cement8,295.3569.00 (0.84%)
Wipro415.602.85 (0.69%)

IOL Chemicals & Pharmaceuticals

BSE: 524164 | NSE: IOLCP | ISIN: INE485C01011 | SECTOR: Chemical Manufacturing

₹471.10 -0.85 (-0.18%)

27 Sep 2023, 10:26 (IST)

  • Open

    473.00

  • High

    483.25

  • Low

    468.40

  • Prev Close

    471.95

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    27.66B

  • Volume

    30.33K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    471.10

  • Ask

    -
View all metrics

Company Description

  • Chemical Manufacturing

  • BSE

    524164

  • NSE

    IOLCP

  • ISIN

    INE485C01011

IOL Chemicals and Pharmaceuticals Limited is an India-based active pharma ingredients (API) based pharmaceutical company. The Company's APIs portfolio covers various therapeutic categories, such as pain management, anti-diabetic, anti-hypertensive, and anti-convulsant, amongst others. The Company operates through two business divisions: Active Pharma Ingredients (API), and Specialty Chemicals. Its API vertical is engaged in research, developing, and providing various essential products that are used by pharma companies. Its API product portfolio includes Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid.

Company Officers

  • Vikas Vij

    Chief Executive Officer

  • Pardeep Khanna

    Chief Financial Officer

  • Abhay Singh

    Vice President, Company Secretary

  • Varinder Gupta

    Managing Director, Executive Director

  • Vikas Gupta

    Joint Managing Director, Executive Director

  • Kushal Rana

    Director - Works